Report Cover

United States Glucagon Market Report & Forecast 2021-2027


United States Glucagon Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
United States Glucagon Market Segment Percentages, By Type, 2020 (%)
    Inject Glucagon
    Nasal Glucagon

United States Glucagon Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
United States Glucagon Market Segment Percentages, By Application, 2020 (%)
    Emergency Kits
    General Use
    Diagnostic & Motility
    Cardiogenic Shock
    Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glucagon revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Glucagon revenues share in United States market, 2020 (%)
Key companies Glucagon sales in United States market, 2016-2021 (Estimated), (K MT)
Key companies Glucagon sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Novo Nordisk
    Eli Lilly
    Fresenius Kabi
    Torrent Labs
    Taj Pharmaceuticals
    Xeris Pharmaceuticals
1 Introduction to Research & Analysis Reports
    1.1 Glucagon Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Glucagon Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Glucagon Overall Market Size
    2.1 United States Glucagon Market Size: 2021 VS 2027
    2.2 United States Glucagon Revenue, Prospects & Forecasts: 2016-2027
    2.3 United States Glucagon Sales: 2016-2027

3 Company Landscape
    3.1 Top Glucagon Players in United States Market
    3.2 Top United States Glucagon Companies Ranked by Revenue
    3.3 United States Glucagon Revenue by Companies
    3.4 United States Glucagon Sales by Companies
    3.5 United States Glucagon Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Glucagon Companies in United States Market, by Revenue in 2020
    3.7 Manufacturers Glucagon Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Glucagon Players in United States Market
        3.8.1 List of Tier 1 Glucagon Companies in United States
        3.8.2 List of Tier 2 and Tier 3 Glucagon Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Glucagon Market Size Markets, 2021 & 2027
        4.1.2 Inject Glucagon
        4.1.3 Nasal Glucagon
    4.2 By Type - United States Glucagon Revenue & Forecasts
        4.2.1 By Type - United States Glucagon Revenue, 2016-2021
        4.2.2 By Type - United States Glucagon Revenue, 2022-2027
        4.2.3 By Type - United States Glucagon Revenue Market Share, 2016-2027
    4.3 By Type - United States Glucagon Sales & Forecasts
        4.3.1 By Type - United States Glucagon Sales, 2016-2021
        4.3.2 By Type - United States Glucagon Sales, 2022-2027
        4.3.3 By Type - United States Glucagon Sales Market Share, 2016-2027
    4.4 By Type - United States Glucagon Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Glucagon Market Size, 2021 & 2027
        5.1.2 Emergency Kits
        5.1.3 General Use
        5.1.4 Diagnostic & Motility
        5.1.5 Cardiogenic Shock
        5.1.6 Others
    5.2 By Application - United States Glucagon Revenue & Forecasts
        5.2.1 By Application - United States Glucagon Revenue, 2016-2021
        5.2.2 By Application - United States Glucagon Revenue, 2022-2027
        5.2.3 By Application - United States Glucagon Revenue Market Share, 2016-2027
    5.3 By Application - United States Glucagon Sales & Forecasts
        5.3.1 By Application - United States Glucagon Sales, 2016-2021
        5.3.2 By Application - United States Glucagon Sales, 2022-2027
        5.3.3 By Application - United States Glucagon Sales Market Share, 2016-2027
    5.4 By Application - United States Glucagon Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
    6.1 Novo Nordisk
        6.1.1 Novo Nordisk Corporation Information
        6.1.2 Novo Nordisk Overview
        6.1.3 Novo Nordisk Glucagon Sales and Revenue in United States Market (2016-2021)
        6.1.4 Novo Nordisk Glucagon Product Description
        6.1.5 Novo Nordisk Recent Developments
    6.2 Eli Lilly
        6.2.1 Eli Lilly Corporation Information
        6.2.2 Eli Lilly Overview
        6.2.3 Eli Lilly Glucagon Sales and Revenue in United States Market (2016-2021)
        6.2.4 Eli Lilly Glucagon Product Description
        6.2.5 Eli Lilly Recent Developments
    6.3 Fresenius Kabi
        6.3.1 Fresenius Kabi Corporation Information
        6.3.2 Fresenius Kabi Overview
        6.3.3 Fresenius Kabi Glucagon Sales and Revenue in United States Market (2016-2021)
        6.3.4 Fresenius Kabi Glucagon Product Description
        6.3.5 Fresenius Kabi Recent Developments
    6.4 Torrent Labs
        6.4.1 Torrent Labs Corporation Information
        6.4.2 Torrent Labs Overview
        6.4.3 Torrent Labs Glucagon Sales and Revenue in United States Market (2016-2021)
        6.4.4 Torrent Labs Glucagon Product Description
        6.4.5 Torrent Labs Recent Developments
    6.5 Taj Pharmaceuticals
        6.5.1 Taj Pharmaceuticals Corporation Information
        6.5.2 Taj Pharmaceuticals Overview
        6.5.3 Taj Pharmaceuticals Glucagon Sales and Revenue in United States Market (2016-2021)
        6.5.4 Taj Pharmaceuticals Glucagon Product Description
        6.5.5 Taj Pharmaceuticals Recent Developments
    6.6 Xeris Pharmaceuticals
        6.6.1 Xeris Pharmaceuticals Corporation Information
        6.6.2 Xeris Pharmaceuticals Overview
        6.6.3 Xeris Pharmaceuticals Glucagon Sales and Revenue in United States Market (2016-2021)
        6.6.4 Xeris Pharmaceuticals Glucagon Product Description
        6.6.5 Xeris Pharmaceuticals Recent Developments

7 United States Glucagon Production Capacity, Analysis
    7.1 United States Glucagon Production Capacity, 2016-2027
    7.2 Glucagon Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
    8.1 Market Opportunities & Trends
    8.2 Market Drivers
    8.3 Market Restraints

9 Glucagon Supply Chain Analysis
    9.1 Glucagon Industry Value Chain
    9.2 Glucagon Upstream Market
    9.3 Glucagon Downstream and Clients
    9.4 Marketing Channels Analysis
        9.4.1 Marketing Channels
        9.4.2 Glucagon Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
    11.1 Note
    11.2 Examples of Clients
    11.3 Author Details
    11.4 Disclaimer

List of Tables Table 1. Key Players of Glucagon in United States Market Table 2. Top Glucagon Players in United States Market, Ranking by Revenue (2019) Table 3. United States Glucagon Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Glucagon Revenue Share by Companies, 2016-2021 Table 5. United States Glucagon Sales by Companies, (K MT), 2016-2021 Table 6. United States Glucagon Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Glucagon Price (2016-2021) & (USD/MT) Table 8. Manufacturers Glucagon Product Type Table 9. List of Tier 1 Glucagon Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Glucagon Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Inject Glucagon Table 12. Major Manufacturers of Nasal Glucagon Table 13. By Type - United States Glucagon Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Glucagon Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Glucagon Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Glucagon Sales (K MT), 2016-2021 Table 17. By Type - United States Glucagon Sales (K MT), 2022-2027 Table 18. By Application - United States Glucagon Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Glucagon Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Glucagon Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Glucagon Sales (K MT), 2016-2021 Table 22. By Application - United States Glucagon Sales (K MT), 2022-2027 Table 23. Novo Nordisk Corporation Information Table 24. Novo Nordisk Description and Major Businesses Table 25. Novo Nordisk Glucagon Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 26. Novo Nordisk Glucagon Product Table 27. Novo Nordisk Recent Developments Table 28. Eli Lilly Corporation Information Table 29. Eli Lilly Description and Major Businesses Table 30. Eli Lilly Glucagon Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 31. Eli Lilly Glucagon Product Table 32. Eli Lilly Recent Developments Table 33. Fresenius Kabi Corporation Information Table 34. Fresenius Kabi Description and Major Businesses Table 35. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 36. Fresenius Kabi Glucagon Product Table 37. Fresenius Kabi Recent Developments Table 38. Torrent Labs Corporation Information Table 39. Torrent Labs Description and Major Businesses Table 40. Torrent Labs Glucagon Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 41. Torrent Labs Glucagon Product Table 42. Torrent Labs Recent Developments Table 43. Taj Pharmaceuticals Corporation Information Table 44. Taj Pharmaceuticals Description and Major Businesses Table 45. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 46. Taj Pharmaceuticals Glucagon Product Table 47. Taj Pharmaceuticals Recent Developments Table 48. Xeris Pharmaceuticals Corporation Information Table 49. Xeris Pharmaceuticals Description and Major Businesses Table 50. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 51. Xeris Pharmaceuticals Glucagon Product Table 52. Xeris Pharmaceuticals Recent Developments Table 53. Glucagon Production Capacity (K MT) of Key Manufacturers in United States Market, 2019-2021 (K MT) Table 54. United States Glucagon Capacity Market Share of Key Manufacturers, 2019-2021 Table 55. Glucagon Market Opportunities & Trends in United States Market Table 56. Glucagon Market Drivers in United States Market Table 57. Glucagon Market Restraints in United States Market Table 58. Glucagon Raw Materials Table 59. Glucagon Raw Materials Suppliers in United States Market Table 60. Typical Glucagon Downstream Table 61. Glucagon Downstream Clients in United States Market Table 62. Glucagon Distributors and Sales Agents in United States Market List of Figures Figure 1. Glucagon Product Picture Figure 2. Glucagon Segment by Type Figure 3. Glucagon Segment by Application Figure 4. United States Glucagon Market Overview: 2020 Figure 5. United States Glucagon Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Glucagon Revenue, 2016-2027 (US$, Mn) Figure 7. Glucagon Sales in United States Market: 2016-2027 (K MT) Figure 8. The Top 3 and 5 Players Market Share by Glucagon Revenue in 2020 Figure 9. Inject Glucagon Product Picture Figure 10. Nasal Glucagon Product Picture Figure 11. By Type - United States Glucagon Sales Market Share, 2016-2027 Figure 12. By Type - United States Glucagon Revenue Market Share, 2016-2027 Figure 13. By Type - United States Glucagon Price (USD/MT), 2016-2027 Figure 14. Emergency Kits Figure 15. General Use Figure 16. Diagnostic & Motility Figure 17. Cardiogenic Shock Figure 18. Others Figure 19. By Application - United States Glucagon Sales Market Share, 2016-2027 Figure 20. By Application - United States Glucagon Revenue Market Share, 2016-2027 Figure 21. By Application - United States Glucagon Price (USD/MT), 2016-2027 Figure 22. Novo Nordisk Glucagon Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Eli Lilly Glucagon Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Fresenius Kabi Glucagon Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. Torrent Labs Glucagon Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Taj Pharmaceuticals Glucagon Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Xeris Pharmaceuticals Glucagon Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. United States Glucagon Production Capacity (K MT), 2016-2027 Figure 29. Glucagon Industry Value Chain Figure 30. Marketing Channels

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us